(±)-HIP-A is a potent non-competitive inhibitor of excitatory amino acid transporters (EAATs), effectively blocking glutamate uptake (IC50 = 17–18 μM); it serves as a lead compound for drugs against ischemia-induced neuronal degeneration and is used in research on neurological disorders.